Registered Nurse in Glen Ridge, NJ Accepting Medicare
7 Registered Nurse nurses found. Showing 1 - 7
 Karen Calhoun, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Bay St, Glen Ridge, NJ 07028 Phone: 717-799-7665 |
Kayla Kristine Paul, Registered Nurse Medicare: Medicare Enrolled Practice Location: 946 Bloomfield Ave, Glen Ridge, NJ 07028 Phone: 973-743-1121 Fax: 973-743-9419 |
Esther Meyers, APN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 311 Bay Ave Ste 100, Glen Ridge, NJ 07028 Phone: 551-996-9250 |
Lisa Reinherz Jennings, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 200 Thomas St, Glen Ridge, NJ 07028 Phone: 646-573-4653 |
Kaitlyn Ettinger, Registered Nurse - Medical-Surgical Medicare: Not Enrolled in Medicare Practice Location: 946 Bloomfield Ave, Glen Ridge, NJ 07028 Phone: 973-743-1121 |
Christina Marie Hess, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 158 Midland Ave, Glen Ridge, NJ 07028 Phone: 609-385-7617 |
Ms. Kelly Abramopaulos, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 946 Bloomfield Ave Ste 1, Glen Ridge, NJ 07028 Phone: 973-743-1121 |
News Archive
Federal deadline on state health insurance 'pools' sparks confrontations
States must tell the federal government whether they will help run new insurance pools for high-risk patients by Friday, which could set up political confrontations, The New York Times reports.
Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting
Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.
Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform
Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced the launch of iSPERSE, the company's novel inhaled dry powder drug delivery platform.
Affymetrix files more patent infringements against Illumina in U.S. and Europe
Affymetrix Inc. has announced that it has filed additional patent infringement lawsuits against Illumina Inc. in the United States District Court for the District of Delaware, in the U.K. High Court of Justice, Chancery Division, Patents Court and in the German, Düsseldorf Regional Court, Patent Division. Affymetrix is seeking all available remedies, including injunctive relief.
› Verified 5 days ago